Spanish customized adjuvant trial (SCAT) based on BRCA1 mRNA levels

• DOI: 10.1200/jco.2008.26.15_suppl.7533
• Publication Date: 2017-02-24T07:33:44Z
• Authors: M. Cobo; B. Massuti; T. Morán; I. Chaib; L. Pérez-Roca; U. Jiménez; D. Aguiar Bujanda; J. González-Larriba; J. Gómez; R. Rosell
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

7533 Background: Patients (p) with low BRCA1 mRNA levels attained longer survival when treated with cisplatin-based chemotherapy (Taron et al. 2004), while p with high BRCA1 levels attained longer ...